 |
| On the 11th, an employee is holding an AstraZeneca (AZ) vaccine bottle that has been vaccinated at a public health center in Jungnang-gu, Seoul. 2021.3.11/News1 © News1 Reporter Yoo Seung-gwan |
Recently, when some European countries stopped vaccination against AstraZeneca (AZ) due to the formation of blood clots, our quarantine authorities said, “The serial number vaccine in question has not been imported into Korea.” It is read that if the reliability of the vaccine is low, it can interfere with the vaccination rate, and it is said that it has started to evolve rapidly.
The central quarantine countermeasures headquarters announced on the 12th that the vaccine with the serial number (batch ABV 5300) in which thromboembolism occurred in relation to the’International Astraneca vaccination suspension trend’ was not imported into Korea.
In addition to the announcement of the existing’Corona 19 domestic outbreak and vaccination status’, as concerns about the’blood clot formation’ from Europe grew, Bang Dae-bon additionally announced the trend of stopping overseas vaccinations.
Earlier, the Austrian Federal Health and Safety Administration (BASG) decided to stop vaccinating the remaining stock after a 49-year-old female nurse died of a blood clotting disorder after vaccinating the AstraZeneca vaccine on the 7th and a 35-year-old female nurse was hospitalized with pulmonary embolism. . All of them had no underlying disease and were vaccinated with the same serial number AstraZeneca vaccine (batch ABV 5300) in the same area.
In addition, △Italy △Denmark △Norway △Iceland △Latvia △Lithuania △Estonia △Luxembourg, etc., have stopped vaccinating the serial number vaccine or AstraZeneca vaccine.
Bang Dae-bon said, “As of 0 o’clock on the 12th, a total of 54,6277 people were vaccinated against the Corona 19 vaccine, but there were no reports of similar adverse reactions such as thromboembolism.”
Even when the first death occurred after vaccination on the 3rd, Bang Dae-bon held an additional briefing to resolve concerns about the vaccine.
Last Wednesday (3rd) was the scheduled day for a back briefing (informal briefing for background explanations other than an official briefing) without regular briefings, but Chung Eun-kyung, director of the Centers for Disease Control and Prevention, conducted an additional briefing.
In a briefing at the time, Commissioner Chung said, “The UK also received Pfizer or AstraZeneca vaccination, and now 402 people have died. However, there has been no confirmed case of causality with vaccination. I think that vaccination would have increased anxiety, but it is safe. Vaccines are being vaccinated.”
To date, the first vaccination of the Corona 19 vaccine has been completed by 54,6277 people (52,6414 AstraZeneca, 10,9863 Pfizer) as of 0 o’clock on the 12th.
Of these, 7648 cases of adverse reactions were reported, and 15 cases of death were reported. Bang Dae-bon judged that, for the eight people whose investigation was completed by the last 7th, it is difficult to admit vaccination, death, and causality.
As such, Bang Dae-bon is trying to immediately resolve concerns about the vaccine. This is because it is important to maintain the speed of vaccination in order to achieve the goal of’generating population immunity in November’.
According to the results of a survey conducted by Gallup Korea, a company specializing in public opinion polls, on 1,004 adults aged 18 and over nationwide on the 23rd to 25th of last month (the sample error is ±3.1% points with a 95% confidence level, and a response rate of 14%). Regarding, 71% of Koreans said that they are willing to inoculate (48%’must be’ and 23%’probably’). On the other hand, opinions that they would not receive vaccinations reached 5% (14% of’probably not going to receive’ vaccinations and’never’). The opinion of’reservation’ also recorded 10%.
With nearly a third of the population showing a negative or reserved position on vaccination, if issues such as’death after vaccination’ and’side effects’ increase, the rejection of vaccination may increase.
In a briefing held on the 11th, Kwon Joon-wook, head of the 2nd vice-president, emphasized, “It is important to maintain the speed of vaccination at a certain rate,” along with the formation of group immunity and the reduction of the spread of the related COVID-19 outbreak and mutation.
Choi Won-seok, a professor of infectious medicine at Korea University Ansan Hospital, explained, “The causal relationship between the AstraZeneca vaccine and the occurrence of blood clots should be evaluated through investigations in the relevant country. However, blood clots are not a type of autoimmune disease, but it is not likely to be related.” did.
He added, “We need to respond to adverse reaction issues as soon as possible,” he added. “Vaccines are not perfect drugs, but because they have more benefits, we recommend vaccination. The government should deal with objective and transparent procedures.”